Covered recipient · General Payments record
ASAD SHEIKH
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2018–2024
$5,418.30
- Reported across 101 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,723.51 | 40 |
| Consulting Fee | $525.00 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Daiichi Sankyo Inc. | $567.76 | 3 |
| SOBI, INC | $240.01 | 2 |
| GlaxoSmithKline, LLC. | $221.59 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $217.21 | 3 |
| Janssen Biotech, Inc. | $183.34 | 4 |
| Acerta Pharma LLC | $158.67 | 3 |
| Ipsen Biopharmaceuticals, Inc | $107.52 | 1 |
| Dendreon Pharmaceuticals LLC | $95.25 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $84.65 | 4 |
| RECORDATI_RARE_DISEASES_INC. | $58.11 | 2 |
| ARRAY BIOPHARMA INC | $39.95 | 2 |
| Sumitomo Pharma America, Inc. | $36.94 | 2 |
| Genentech USA, Inc. | $31.92 | 2 |
| Gilead Sciences, Inc. | $23.97 | 1 |
| Lilly USA, LLC | $23.88 | 1 |
| E.R. Squibb & Sons, L.L.C. | $22.79 | 1 |
| PUMA BIOTECHNOLOGY, INC. | $21.98 | 1 |
| BeiGene USA, Inc. | $21.57 | 1 |
| GENZYME CORPORATION | $21.11 | 1 |
| Merck Sharp & Dohme Corporation | $20.58 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $18.70 | 1 |
| ADC Therapeutics America, Inc. | $16.40 | 1 |
| Celgene Corporation | $14.61 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (41)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.